BioSpace News Archive

AnchorDx, DiaCarta Partner Developing Novel Cancer Screening Tests

AnchorDx announced that it has entered into a long-term collaboration with DiaCarta, a precision molecular diagnostics company and developer of novel oncology and infectious disease tests, for product development and global commercialization in the cancer screening arena.

November 13, 2023
·
3 min read
Business

Nereid Therapeutics Appoints Michael Kauffman as CEO

Nereid Therapeutics announced today that Michael Kauffman, M.D., Ph.D., has joined the company as President and Chief Executive Officer.

November 13, 2023
·
3 min read
CymaBay Announces an Oral Presentation of Seladelpar Phase 3 Pivotal Results in Primary Biliary Cholangitis at the Late Breaker Session of the Liver Meeting®

CymaBay Therapeutics, Inc. today announced that the results from its RESPONSE Phase 3 registration study evaluating seladelpar, a potent, selective, orally-active delpar, or PPAR

November 13, 2023
·
1 min read
Bio NC

Tune Therapeutics Reveals Epigenetic Editing Program Targeting Hepatitis B Virus

Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection.

November 13, 2023
·
3 min read
Pharm Country

UroGen will Present Scientific Advances in Bladder Cancer at the Annual Meeting of the Society of Urologic Oncology

UroGen Pharma Ltd. will highlight data from two key Phase 3 trials evaluating UGN-102, an investigational treatment in development for LG-IR-NMIBC at the 2023 Society of Urologic Oncology (SUO) annual meeting, November 28-December 1 in Washington D.C.

November 13, 2023
·
6 min read
BioCapital

KeraLink International Provides $2.5 Million in Seed Funding to Enable Development of Bioengineered Corneal Implants

KeraLink International announced $2.5 million in seed funding in Pantheon Vision to launch the development of a novel advancement to help eradicate corneal blindness in both developed and low- and middle-income countries.

November 13, 2023
·
2 min read
Business

Tevard Biosciences appoints Dr. Gregory Robinson as Chief Scientific Officer

Tevard Biosciences, Inc., the pioneer of tRNA-based therapies and other mRNA-modulating treatments for genetic diseases, announced that it has appointed Dr. Gregory Robinson as Chief Scientific Officer.

November 13, 2023
·
2 min read
Business

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023

ImmuCell Corporation, a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, announced its unaudited financial results for the quarter ended September 30, 2023.

November 13, 2023
·
10 min read
Business

Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results

Allakos Inc., a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, provided a business update and reported financial results for the third quarter ended September 30, 2023.

November 13, 2023
·
7 min read
Business

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, reported financial results and business highlights for the third quarter ended September 30, 2023.

November 13, 2023
·
12 min read